Sharemaestro Newsreel

LifeMD Inc reports results for the quarter ended June 30 - Earnings Summary

LifeMD Inc has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a brief announcement of these financial results. To access the full details, readers are directed to the complete article available on TradingView.

10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5%

Health Catalyst (NASDAQ:HCAT) reported Q2 CY2026 results that surpassed revenue expectations but showed a 12.7% year-on-year sales decline. Despite exceeding revenue and adjusted EBITDA estimates, the company's stock dropped 25.5% due to lower-than-expected revenue guidance for the next quarter and the full year, along …

M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix

Health Catalyst, a healthcare intelligence company, has completed the sale of its mid-revenue cycle business, Vitalware, to Med-Metrix for $147 million. This divestiture allows Health Catalyst to repay its credit facility, eliminating approximately $19 million in annual interest expense, and focus its capital and …

Doximity (NYSE:DOCS) Surges on AI Engagement Momentum Despite EPS Miss and Soft Guidance

Doximity (NYSE:DOCS) saw its shares surge by 34% in after-hours trading despite missing EPS estimates and providing soft guidance, indicating that investors are focusing on the company's strong AI engagement momentum and product adoption. The company's Q1 fiscal 2027 revenue was in line with …

HEALTH CATALYST ($HCAT) Releases Q2 2026 Earnings

HEALTH CATALYST ($HCAT) announced its Q2 2026 earnings, reporting $0.04 per share, beating estimates by $0.01, and revenue of $70.49 million, surpassing estimates. Despite strong earnings, the stock price decreased by 27.83% since market close. The article also details recent hedge fund activity in …

[10-Q] HEALTHSTREAM INC Quarterly Earnings Report

HealthStream Inc. (HSTM) reported its unaudited quarterly earnings for the period ended June 30, 2026, including financial statements and management's discussion and analysis. The company disclosed $66.7 million in cash and marketable securities and an ongoing cybersecurity investigation that has not materially impacted operations. …

Omada Health publishes investor presentation outlining between-visit virtual care model for chronic conditions

Omada Health has released an investor presentation detailing its between-visit virtual care model for chronic cardiometabolic conditions, aiming to serve as a multi-condition platform. The company reported strong Q2 2026 revenue of $88 million, a 43% year-over-year increase, with 1.1 million total members and …

10X GENOMICS ($TXG) Releases Q2 2026 Earnings

Doximity’s (NYSE:DOCS) Q2 CY2026: Beats On Revenue

Health Catalyst Reports Second Quarter 2026 Results

Health Catalyst (Nasdaq: HCAT) reported its financial results for the second quarter ended June 30, 2026, exceeding revenue guidance and adjusting EBITDA. The company's CEO, Ben Albert, highlighted the Vitalware divestiture and debt repayment as significant balance sheet improvements. Health Catalyst also provided its …

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health announced strong second-quarter 2026 financial results, with revenue growing 43% year-over-year to $88 million and a record gross margin of 73%. The company also disclosed a CEO transition, with co-founder Sean Duffy moving to Executive Chair and current President Wei-Li Shao becoming …

Omada Health reports 43% revenue growth, leadership transition

Omada Health Inc. reported a 43% revenue growth in the second quarter of 2026, reaching $88 million, alongside a net income of $5 million. The virtual healthcare provider also announced a leadership transition, with Wei-Li Shao appointed as the new CEO effective January 1, …

Weave Communications, Inc. 2026: Revenue $67.54M, EPS ($0.05) — 10-Q Summary

Weave Communications, Inc. (WEAV) reported its 2026 quarterly results, showing a revenue increase of 15.5% to $67.54 million and a significant reduction in net loss to ($4.26 million) from ($8.71 million) in the prior year. Diluted loss per share improved from ($0.11) to ($0.05). …

10x Genomics (NASDAQ: TXG) swings to Q2 loss but lifts 2026 revenue guide

Weave Communications, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2026 and the Full Year Ending December 31, 2026

10x Genomics Reports Second Quarter 2026 Financial Results

OMADA HEALTH ($OMDA) Releases Q2 2026 Earnings, Stock Rises

OMADA HEALTH ($OMDA) reported strong Q2 2026 earnings, surpassing both earnings per share and revenue estimates, leading to a 1.54% stock price increase. Despite insider sales totaling over $4.7 million in the past six months, institutional investors have shown mixed activity with some significant …

Earnings Flash (PRVA) Privia Health Group, Inc. Reports Q2 Revenue $632.6M, Vs. FactSet Est of $597.3M

Privia Health Group, Inc. (PRVA) announced its Q2 revenue of $632.6 million, significantly surpassing the FactSet estimate of $597.3 million. This indicates stronger-than-anticipated financial performance for the quarter.

Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ...

Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billion–$2.7 billion, …

TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20

TD Cowen has reiterated its Buy rating for Schrodinger (SDGR.US), maintaining a target price of $20. This indicates the firm's continued confidence in the company's financial prospects and stock performance.

Omada Health earnings on deck: GLP-1 strategy in focus By Investing.com

Omada Health is set to report its second-quarter earnings, with investors focusing on its strategy to leverage the growing GLP-1 weight-loss medication market. The company is positioning itself as a "GLP-1 gatekeeper" for employers managing costs and has shown strong revenue growth and margin …

VSee Health, Inc. Revenue Breakdown – OTC:VSEE

This article provides a revenue breakdown for VSee Health, Inc. (OTC:VSEE), highlighting that the United States is the primary contributor to its revenue. In the last year, the U.S. segment generated $14.62 million, an increase from $10.42 million the previous year. The data is …

LifeMD, Inc. Q2 2026: Revenue $47.28M, EPS $(0.16) — 10-Q Summary

LifeMD, Inc. reported its second-quarter 2026 results, showing a revenue of $47.28 million, a 3.6% decrease year-over-year, and a net loss of $7.86 million, significantly wider than the previous year's loss. The diluted loss per share was $(0.16). Despite a decline in online product …

Equity in earnings of VSee Health, Inc. – OTC:VSEE

The article reports on the equity in earnings of VSee Health, Inc. (OTC:VSEE). It provides an overview of the company's financial data as available on TradingView. The content is primarily a listing of navigation and footer elements typical of a financial data platform.

Spotlight On Promising Penny Stocks For August 2026

This article highlights three promising penny stocks for August 2026: So-Young International (SY), Caribou Biosciences (CRBU), and The Honest Company (HNST). Despite their current unprofitability, each company demonstrates unique strengths such as strong growth forecasts, solid financial health (low debt, ample cash runway), or …

Hinge Health (HNGE) Agrees To Acquire A Digestive Care Company And Enters GI Care

Weave Communications earnings matched, revenue topped estimates

Weave Communications (NYSE: WEAV) reported second-quarter earnings per share of $0.04, matching analyst estimates. The company's revenue for the quarter was $67.5 million, exceeding the consensus estimate of $66.78 million. Weave Communications' stock price has risen 12.12% in the last three months but is …

VSee Health, Inc. Balance Sheet – OTC:VSEE

VSee Health, Inc. (OTC:VSEE) reported its Q1 2026 financial position, showing total assets at $19.02 million, a 15.15% decrease from Q4 2025. Total liabilities also decreased by 25.15% to $12.70 million in the same quarter. The report provides a snapshot of the company's balance …

CareCloud (NASDAQ:CCLD) Updates FY 2026 Earnings Guidance

Privia Health Group Releases Q2 2026 Financial Results

Privia Health Group (PRVA) exceeded Q2 2026 earnings expectations, reporting adjusted EPS of $0.19 against a $0.07 estimate, and revenue of $632.6M, a 21.4% increase year-over-year. The company's growth was driven by its expanding provider network and value-based care arrangements, with full-year revenue guidance …

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Definitive Healthcare (Nasdaq: DH) has announced an early adopter program for its new AI-powered healthcare intelligence platform, providing select organizations with early access. The platform integrates claims, provider, consumer, and expert data with conversational AI to surface insights, optimize market opportunities, and improve decision-making. …

Health Catalyst Tries To Reset With A Vitalware Sale

Health Catalyst (HCAT) plans to sell its Vitalware product line for $147 million to reduce debt and improve margins, aiming to refocus on its higher-growth Ignite platform and AI-enabled solutions. While the company faces significant operating losses and negative returns on invested capital, the …

Return on assets % of VSEE HEALTH INC – OTC:VSEE

This article provides financial data for VSee Health, Inc. (OTC:VSEE), specifically focusing on its return on assets percentage. It indicates the stock's market status as closed with no recent trades, and presents information about its financial overview on the TradingView platform.

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and disclosed significant accounting issues. The investigation follows a substantial decline in Simulations Plus's share price after these announcements, including a $77.2 million non-cash impairment …

First Eagle Investment Management (SLP) reports 5.30% beneficial stake in Simulations Plus

First Eagle Investment Management, LLC has reported a beneficial ownership of 5.30% in Simulations Plus Inc., totaling 4,674,801.24 shares. The firm acts as an investment adviser for various clients, holding sole voting and dispositive power over 1,070,582 shares. This disclosure, filed under SCHEDULE 13G, …